Regional Management Corp (RM) Stock News

Marvell Technology demonstrates stronger revenue growth than ARM, with consistent quarter-over-quarter increases driven by high demand for its AI-related semiconductor solutions from tech giants. ARM shows more uneven growth patterns but recent quarters suggest acceleration as it pivots toward data center CPU production. Marvell raised its FY2028 revenue outlook to $20 billion and projects $70-90 billion by FY2031, indicating confidence in sustained growth.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Papa John's International (PZZA) on behalf of investors who purchased stock between August 7, 2025 and August 5, 2026. The lawsuit alleges that Papa John's made materially false and misleading statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, requiring a shift toward increased promotional efforts.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (NASDAQ: CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

Rosen Law Firm is reminding investors who purchased Tigo Energy securities between February 24, 2026 and August 4, 2026 of the November 23, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Tigo made materially false and misleading statements regarding revenue projections based on an EG4 partnership that would not generate material revenue until Q4 2026 at the earliest, lacking a reasonable basis for the projections.

Rosen Law Firm has filed securities class action lawsuits against Taboola.com Ltd., The Simply Good Foods Company, and Tigo Energy, Inc. The firm is seeking lead plaintiffs and encouraging investors who purchased securities during specified class periods to join the litigation. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

Rosen Law Firm has filed class action lawsuits against Qfin Holdings, Inc. and Anavex Life Sciences Corp. on behalf of investors who purchased securities during specified periods. The Qfin lawsuit alleges defendants made false statements about business resilience and downplayed regulatory impacts. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

Vallourec announces the appointment of Isabelle Quéméneur as Group Chief Digital and Information Officer, effective October 5, 2026. Quéméneur, previously Chief Technology Officer at Danone, joins Vallourec's Executive Committee to lead digital transformation initiatives focused on customer value creation and modernizing team operations in response to cybersecurity and AI challenges.

Vallourec announces the appointment of Isabelle Quéméneur as Director of Digital & IT Systems, effective October 5, 2026. She joins the Executive Committee and brings extensive experience from her previous role as CTO at Danone, along with a background in technology leadership at major international companies including Société Générale, AXA, and Sanofi.

Rosen Law Firm is soliciting investors who purchased AppLovin Corporation (NASDAQ: APP) securities between February 12, 2026 and August 5, 2026 to join a class action lawsuit. The lawsuit alleges that AppLovin made false statements regarding its generative AI video creative feature, overstated AI model improvements, and misrepresented the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

A securities class action lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging the company made materially false and misleading statements about its iLet Bionic Pancreas insulin pump. The FDA reportedly raised serious safety concerns including device malfunctions and dangerously high insulin dosing causing hypoglycemic events. The lawsuit claims Beta Bionics failed to implement meaningful corrective actions despite thousands of complaints. Investors who purchased stock between July 30, 2025 and February 24, 2026 may be eligible for compensation, with a November 3, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm reminds investors in Alarum Technologies Ltd. (NASDAQ: ALAR) who purchased securities between March 20, 2025 and July 2, 2026 of the October 5, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Alarum Technologies and its subsidiary NetNut engaged in illegal activity by linking customer home internet devices to unauthorized networks without consent, enabling cybercriminals to conceal their locations. Defendants allegedly made false and misleading statements about the company's business and prospects, causing investor damages.

Rosen Law Firm is reminding investors in Alibaba Group Holding Limited, Flotek Industries, Inc., and The Simply Good Foods Company of upcoming lead plaintiff deadlines in securities class actions. The Alibaba lawsuit alleges the company made false statements regarding military affiliations and AI model distillation attacks. Investors with losses exceeding $100,000 are encouraged to seek counsel before the October 5, 2026 deadline for Alibaba.

Rosen Law Firm is notifying investors of upcoming lead plaintiff deadlines in securities class action lawsuits against Flotek Industries, The Simply Good Foods Company, and Dun & Bradstreet Holdings. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Flotek Industries (FTK), where investors who purchased securities between August 3-17, 2026 may be entitled to compensation. The lawsuit alleges that Flotek made materially false statements regarding a Puerto Rico Electric Power Authority contract, failing to disclose credible doubts about the consortium's capacity to deliver on the project. The lead plaintiff deadline is October 26, 2026.

Rosen Law Firm is reminding investors in Blaize Holdings, Smartsheet Inc., and DICK'S Sporting Goods of upcoming lead plaintiff deadlines in securities class actions. The lawsuits allege false statements, improper revenue recognition, and undisclosed business practices that caused investor damages.

Rosen Law Firm has filed a class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding cardiac risks associated with its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The firm is seeking lead plaintiffs with a deadline of November 3, 2026.

Rosen Law Firm is soliciting investors who purchased Baidu securities between November 18, 2025 and August 17, 2026 to join a class action lawsuit. The lawsuit alleges that Baidu made false statements about its AI business's ability to offset declines in its legacy online marketing business, resulting in misleading revenue projections and investor damages.

A securities class action lawsuit has been filed against AST SpaceMobile, Inc. for allegedly making false and misleading statements regarding its capital requirements, liquidity position, competitive standing in the satellite D2C market, and user adoption rates. Investors who purchased securities between March 4, 2025 and July 15, 2026 may be eligible for compensation. The lead plaintiff deadline is November 13, 2026.

A securities class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly stated coverage would begin July 1, 2026, while concealing material adverse facts about the actual timeline, causing investors to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

Rosen Law Firm has filed a class action lawsuit against Anavex Life Sciences Corp. (AVXL) on behalf of investors who purchased securities between November 26, 2025 and August 28, 2026. The lawsuit alleges that the company made false and misleading statements regarding adequate internal controls, understated regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresented its business operations and prospects. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

A class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product (neffy) with CVS Caremark. The company reportedly expressed confidence that coverage would begin July 1, 2026, while failing to adequately disclose risks that the deadline might not be met, potentially impacting summer and back-to-school sales.

Rosen Law Firm is soliciting investors in Beta Bionics, Inc. (NASDAQ: BBNX) who purchased stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, concealing that the FDA had raised serious safety concerns including device malfunctions causing dangerously high insulin dosing and thousands of complaints. The lead plaintiff deadline is November 3, 2026.

America's Car-Mart reported a dramatic decline in Q1 FY2027 results, with retail units sold dropping 81.9% and revenue falling 57.3% year-over-year. The poor financial results triggered a stock price decline, prompting a securities law investigation by Holzer & Holzer, LLC into potential federal securities law violations.

Rosen Law Firm has filed a securities class action lawsuit against Anavex Life Sciences Corp. (AVXL) on behalf of investors who purchased securities between November 26, 2025 and August 28, 2026. The lawsuit alleges the company made false and misleading statements regarding inadequate internal controls, understated regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresented its business operations and prospects. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

Pomerantz LLP is investigating securities fraud claims against America's Car-Mart (CRMT) following a series of negative disclosures. The company delayed its annual report due to inadequate loan modification disclosures, later restating financial statements. Subsequent earnings reports revealed declining sales volumes (5.7% drop), increased net charge-offs (9.5% vs 6.6%), and a dramatic 57.3% year-over-year revenue decline, causing the stock to plummet from $57.26 to $1.48 per share.

A securities class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (SPRY) for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly misled investors about expected July 1, 2026 coverage, causing shareholders to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. GoDaddy Inc. faces allegations of making false statements about customer growth strategy and average order size, with an October 20, 2026 lead plaintiff deadline. The firm is also handling class actions for FuelCell Energy Inc. and The Simply Good Foods Company with similar investor protection deadlines.

A securities class action lawsuit has been filed against Lincoln Educational Services Corporation (LINC) alleging that defendants made false and misleading statements about the company's admissions process and student conversion rates. The lawsuit claims the company failed to disclose a significant drop in student starts relative to enrollment, and that positive statements about the business lacked a reasonable basis. Investors who purchased LINC securities between May 11, 2026 and August 9, 2026 may be eligible for compensation. The lead plaintiff deadline is November 10, 2026.

Rosen Law Firm announces a securities class action lawsuit against Flotek Industries, Inc. (FTK) for allegedly making materially false and misleading statements regarding a Puerto Rico Electric Power Authority (PREPA) power generation project contract. The lawsuit claims defendants failed to disclose credible doubts about the consortium parties' experience and financial capacity, creating risk that contract revenue would not be realized. The lead plaintiff deadline is October 26, 2026.

Rosen Law Firm reminds investors in Blaize Holdings, Inc. (NASDAQ: BZAI) of the October 5, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Blaize made false statements about business transactions, improperly recognized revenue, and misled investors about company growth.